Finance

Beta
Lists
ETON:NASDAQ
Eton Pharmaceuticals Inc
$29.95
+2.81%
(+0.82) 1D
$29.95
0.00% (0.00)
After hours
Closed: Jun 8, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ETON...
Open
$29.43
High
$30.06
Low
$28.79
Mkt. cap
820.40M
Avg. vol.
421.44K
Volume
0.00
52-wk high
$35.66
52-wk low
$13.08
EPS
-$0.06
Beta
0.87
Shares outstanding
27.39M
No. of employees
44
Open
$29.43
High
$30.06
Low
$28.79
Mkt. cap
820.40M
Avg. vol.
421.44K
Volume
0.00
52-wk high
$35.66
52-wk low
$13.08
EPS
-$0.06
Beta
0.87
Shares outstanding
27.39M
No. of employees
44
Analyst outlook
Analyst Ratings
Based on 3 analysts giving stock ratings to ETON in the past 3 months
Strong Buy
Buy
3
Hold
0
Sell
0
12 month forecast
Based on 3 Wall Street analysts offering 12 month price targets for ETON in the last 3 months.
Highest
Current $29.95
$57.00 (+90.32%)
Average
$48.50 (+61.94%)
Lowest
$40.00 (+33.56%)
News stories
From sources across the web
About Eton Pharmaceuticals Inc
CEO-
Employees44
Founded2017
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
18.93M
22.46M
21.28M
24.27M
Cost of goods sold
5.80M
13.28M
6.76M
9.18M
Cost of revenue
5.80M
13.28M
6.76M
9.18M
Research and development expenses
3.71M
1.11M
1.78M
1.88M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9.69M
8.11M
8.28M
10.45M
Operating expense
13.40M
9.22M
10.06M
12.32M
Total operating expenses
19.20M
22.50M
16.82M
21.50M
Operating income
-268.00K
-39.00K
4.47M
2.76M
Other non operating income
-
-
-
-
EBT including unusual items
-2.52M
-1.96M
1.41M
1.57M
EBT excluding unusual items
-1.31M
-631.00K
3.42M
1.92M
Income tax expense
66.00K
-28.00K
-69.00K
20.00K
Effective tax rate
-2.62%
1.43%
-4.88%
1.27%
Other operating expenses
-
-
-
-
Net income
-2.58M
-1.93M
1.48M
1.55M
Net profit margin
-13.66%
-8.58%
6.97%
6.40%
Earnings per share
0.03
0.04
0.19
0.14
Interest and investment income
-
620.00K
158.00K
296.00K
Interest expense
-1.04M
-1.21M
-1.21M
-1.14M
Net interest expenses
-1.04M
-592.00K
-1.05M
-840.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
737.00K
970.00K
5.48M
3.90M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more